Musli Thyropeutics ^{For Profit}

Musli Thyropeutics is a pharmaceutical company that specializes in developing a combination of repurposed drugs for cancer treatment. It focuses on glioblastoma multiforme and brain metastases from lung and other cancers and other aggressive cancers. The company was founded in 2014 and headquartered in HaMerkaz, Israel.